Bristol Adds Warning to Blood-Thinning Drug
From Bloomberg News
Bristol-Myers Squibb Co. added a warning to the blood thinner Coumadin, saying the drug can cause “major or fatal” bleeding.
A copy of the advice, outlined for emphasis in black on the information supplied with the drug, was posted on the Food and Drug Administration’s website. Coumadin’s generic name is warfarin sodium.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.